杆菌感染的管理:缅甸共识报告
Than Than Aye1, Nwe Ni2, Tin Tin May1
1Department of Gastroenterology, Yangon General Hospital, University of Medicine 1, Yangon, Myanmar.
Helicobacter
|November 14, 2025
概括
缅甸制定了第一个共识指南,用于治疗Helicobacter pylori (H. pylori) 感染. 本指南涉及测试和治疗策略,以应对日益增长的耐药性和提高H. pylori根除率.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 杆菌 (H. pylori) 感染在缅甸很普遍,导致严重的并发症,如胃潰瘍出血和胃癌.
- 缅甸面临胃癌的中等风险,这强调了需要有效的H. pylori管理的需要.
- 抗生素耐药性增加,特别是对三重疗法,需要在缅甸对H. pylori制定标准化的管理指南.
研究的目的:
- 建立缅甸Helicobacter pylori (H. pylori) 感染管理临床实践的第一个共识指南.
- 为诊断和治疗H. pylori提供基于证据的建议,考虑当地临床实践和现有证据.
- 为应对抗生素耐药性在H. pylori治疗中的日益增长的挑战.
主要方法:
- 一个由39名来自缅甸肠道和肝脏协会 (MGLS) 的胃肠道专家和临床医生组成的共识小组成立.
- 在综合会议上采用了德尔菲方法,以制定关于H. pylori管理的共识声明.
- 建议遵循推,评估,开发和评估 (GRADE) 系统的分级,共识需要≥80%的协议.
主要成果:
- 在26个声明中达成共识,涵盖了H. pylori管理的关键方面:测试谁,如何测试,治疗谁以及如何治疗.
- 该指南强调治疗后确认H. pylori状态,以确保成功根除.
- 建议是基于全球文献和指导方针,特别关注缅甸的证据,因为当地高质量数据有限.
结论:
- 这份共识指南为缅甸H. pylori感染的正确诊断和治疗提供了关键的框架.
- 有效的H. pylori根除对于防止抗生素耐药性的进一步发展至关重要.
- 未来的研究应该专注于第三线治疗方案和开发针对H. pylori的抗生素敏感性测试.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Peptic Ulcer Disease IV: Management
419
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
419
Gastritis III: Clinical Manifestations and Management
1.1K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
522
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
522
Peptic Ulcer Disease V: Surgical Management and Nursing Care
798
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
798
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K


